• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Gabon Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Gabon Pharmaceuticals and Healthcare Report Q1 2013

  • ID: 2372999
  • January 2013
  • Region: Gabon
  • 34 pages
  • Business Monitor International

BMI View:

The recent announcement that Gabon's National Drug Office budget for 2012 would be almost doubled compared with 2011 will be welcomed by pharmaceutical companies. However, we note that the absolute funding is still very low and the vast majority of expenditure will be on low-margin essential medicines. Due to tepid economic growth, our outlook for Gabon's pharmaceutical market is below that expected to be posted by many of its sub-Saharan Africa neighbours.

Headline Expenditure Forecasts:

- Pharmaceuticals: XAF63.8bn (US$135mn) in 2011 to XAF68.4bn (US$132mn) in 2012;
+7.2% in local currency and -1.9% in US dollar terms. Forecast very slightly up in US dollar terms compared with Q312.

- Healthcare: XAF256bn (US$541mn) in 2011 to XAF284bn (US$551mn) in 2012; +11.2% in local currency and +1.8% in US dollar terms. Forecast very slightly up in US dollar terms compared with Q312.

- Medical Devices: XAF11.1bn (US$24mn) in 2011 to XAF12.1bn (US$23mn) in 2012; +8.9
%in local currency and -0.3% in US dollar terms. Forecast very slightly up in US dollar terms compared with Q312.

Risk/Reward Rating:

Gabon's RRR score, which measures READ MORE >

Executive Summary 5

Pharmaceutical Risk/Reward Ratings 7
Table: MEA Pharmaceuticals & Healthcare Risk/Reward Ratings (RRRs), Q113 7

Rewards 8

Risks 9

Market Overview 10

Regulatory Regime 12

Industry Forecast Scenario 13

Overall Market Forecast 13
Table: Pharmaceutical Sales, 2008-2016 14

Key Growth Factors - Industry 15
Table: Overall Healthcare Expenditure, 2008-2016 17
Table: Governmental Healthcare Expenditure, 2008-2016 17
Table: Private Healthcare Expenditure, 2008-2016 18

Epidemiology 19

Recent Market Developments 21

Key Growth Factors - Macroeconomic 22
Table: Economic Activity 23

Demographic Outlook 24
Table: Population By Age Group, 1990-2020 ('000) 25
Table: Population By Age Group, 1990-2020 (% of total) 25
Table: Key Population Ratios, 1990-2020 26
Table: Rural/Urban Population Split, 1990-2020 27

Glossary 28

BMI Methodology 30

How We Generate Our Pharmaceutical Industry Forecasts 30

Pharmaceutical Risk/Reward Ratings Methodology 31

Ratings Overview 31
Table: Pharmaceutical Risk/Reward Indicators 31

Weighting 33
Table: Weighting Of Components 33

Sources 33

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos